2BBBullish & Bearish
Estrella Immunopharma, Inc. (ESLA) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 20 out of 100.
Estrella Immunopharma, Inc.’s current 2BB score is 20 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 9 | Very Low |
| Momentum | 43 | Stable |
| Financial strength | 0 | Very Weak |
| Quality | 20 | Weak |
| Risk | 59 | Moderate |
| Headquarters | Emeryville, California, United States |
| Founded | 2006 |
| 52-week range | $0.68 – $3.15 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2026-11-10 | — | -0.0816 | — | $0.00 |
| 2026-03-18 | -0.35 | -0.1836 | — | — |